vs
PUMA BIOTECHNOLOGY, INC.（PBYI）与POWER INTEGRATIONS INC（POWI）财务数据对比。点击上方公司名可切换其他公司
POWER INTEGRATIONS INC的季度营收约是PUMA BIOTECHNOLOGY, INC.的1.4倍（$103.2M vs $75.5M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs -1.9%），POWER INTEGRATIONS INC自由现金流更多（$19.2M vs $14.4M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 6.1%）
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
Power Integrations Inc.是美国头部电力公用事业企业，业务覆盖美国本土11个州，服务超500万用户，在全美电力供应领域拥有领先的市场地位与成熟的运营体系。
PBYI vs POWI — 直观对比
营收规模更大
POWI
是对方的1.4倍
$75.5M
营收增速更快
PBYI
高出29.7%
-1.9%
自由现金流更多
POWI
多$4.8M
$14.4M
两年增速更快
PBYI
近两年复合增速
6.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $75.5M | $103.2M |
| 净利润 | — | $13.3M |
| 毛利率 | 69.3% | 52.9% |
| 营业利润率 | 22.7% | 8.5% |
| 净利率 | — | 12.9% |
| 营收同比 | 27.7% | -1.9% |
| 净利润同比 | — | 45.4% |
| 每股收益（稀释后） | $0.26 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PBYIPOWI
| Q4 25 | $75.5M | $103.2M | ||
| Q3 25 | $54.5M | $118.9M | ||
| Q2 25 | $52.4M | $115.9M | ||
| Q1 25 | $46.0M | $105.5M | ||
| Q4 24 | $59.1M | $105.3M | ||
| Q3 24 | $80.5M | $115.8M | ||
| Q2 24 | $47.1M | $106.2M | ||
| Q1 24 | $43.8M | $91.7M |
净利润PBYIPOWI
| Q4 25 | — | $13.3M | ||
| Q3 25 | $8.8M | $-1.4M | ||
| Q2 25 | $5.9M | $1.4M | ||
| Q1 25 | $3.0M | $8.8M | ||
| Q4 24 | — | $9.1M | ||
| Q3 24 | $20.3M | $14.3M | ||
| Q2 24 | $-4.5M | $4.8M | ||
| Q1 24 | $-4.8M | $4.0M |
毛利率PBYIPOWI
| Q4 25 | 69.3% | 52.9% | ||
| Q3 25 | 77.7% | 54.5% | ||
| Q2 25 | 76.5% | 55.2% | ||
| Q1 25 | 77.1% | 55.2% | ||
| Q4 24 | 76.4% | 54.4% | ||
| Q3 24 | 63.9% | 54.5% | ||
| Q2 24 | 77.4% | 53.2% | ||
| Q1 24 | 75.5% | 52.1% |
营业利润率PBYIPOWI
| Q4 25 | 22.7% | 8.5% | ||
| Q3 25 | 17.6% | -3.3% | ||
| Q2 25 | 12.7% | -1.2% | ||
| Q1 25 | 8.7% | 6.4% | ||
| Q4 24 | 22.6% | 3.7% | ||
| Q3 24 | 27.4% | 10.0% | ||
| Q2 24 | -4.6% | 1.8% | ||
| Q1 24 | -5.3% | 0.5% |
净利率PBYIPOWI
| Q4 25 | — | 12.9% | ||
| Q3 25 | 16.2% | -1.1% | ||
| Q2 25 | 11.2% | 1.2% | ||
| Q1 25 | 6.5% | 8.3% | ||
| Q4 24 | — | 8.7% | ||
| Q3 24 | 25.2% | 12.3% | ||
| Q2 24 | -9.6% | 4.6% | ||
| Q1 24 | -11.0% | 4.3% |
每股收益（稀释后）PBYIPOWI
| Q4 25 | $0.26 | $0.24 | ||
| Q3 25 | $0.17 | $-0.02 | ||
| Q2 25 | $0.12 | $0.02 | ||
| Q1 25 | $0.06 | $0.15 | ||
| Q4 24 | $0.40 | $0.15 | ||
| Q3 24 | $0.41 | $0.25 | ||
| Q2 24 | $-0.09 | $0.09 | ||
| Q1 24 | $-0.10 | $0.07 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $97.5M | $249.5M |
| 总债务越低越好 | $22.7M | — |
| 股东权益账面价值 | $130.3M | $672.8M |
| 总资产 | $216.3M | $772.2M |
| 负债/权益比越低杠杆越低 | 0.17× | — |
8季度趋势，按日历期对齐
现金及短期投资PBYIPOWI
| Q4 25 | $97.5M | $249.5M | ||
| Q3 25 | $94.4M | $241.9M | ||
| Q2 25 | $96.0M | $268.7M | ||
| Q1 25 | $93.2M | $289.3M | ||
| Q4 24 | $101.0M | $300.0M | ||
| Q3 24 | $96.7M | $303.8M | ||
| Q2 24 | $96.8M | $290.5M | ||
| Q1 24 | $107.2M | $299.6M |
总债务PBYIPOWI
| Q4 25 | $22.7M | — | ||
| Q3 25 | $34.0M | — | ||
| Q2 25 | $45.3M | — | ||
| Q1 25 | $56.7M | — | ||
| Q4 24 | $68.0M | — | ||
| Q3 24 | $79.3M | — | ||
| Q2 24 | $90.7M | — | ||
| Q1 24 | $102.0M | — |
股东权益PBYIPOWI
| Q4 25 | $130.3M | $672.8M | ||
| Q3 25 | $115.3M | $672.0M | ||
| Q2 25 | $104.7M | $703.8M | ||
| Q1 25 | $97.1M | $735.8M | ||
| Q4 24 | $92.1M | $749.8M | ||
| Q3 24 | $71.1M | $749.2M | ||
| Q2 24 | $48.5M | $730.7M | ||
| Q1 24 | $51.0M | $738.2M |
总资产PBYIPOWI
| Q4 25 | $216.3M | $772.2M | ||
| Q3 25 | $202.9M | $772.5M | ||
| Q2 25 | $194.9M | $797.5M | ||
| Q1 25 | $196.2M | $814.4M | ||
| Q4 24 | $213.3M | $828.8M | ||
| Q3 24 | $220.7M | $825.0M | ||
| Q2 24 | $205.0M | $804.8M | ||
| Q1 24 | $214.1M | $805.8M |
负债/权益比PBYIPOWI
| Q4 25 | 0.17× | — | ||
| Q3 25 | 0.30× | — | ||
| Q2 25 | 0.43× | — | ||
| Q1 25 | 0.58× | — | ||
| Q4 24 | 0.74× | — | ||
| Q3 24 | 1.12× | — | ||
| Q2 24 | 1.87× | — | ||
| Q1 24 | 2.00× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $14.4M | $26.2M |
| 自由现金流经营现金流 - 资本支出 | $14.4M | $19.2M |
| 自由现金流率自由现金流/营收 | 19.1% | 18.6% |
| 资本支出强度资本支出/营收 | 0.0% | 6.8% |
| 现金转化率经营现金流/净利润 | — | 1.97× |
| 过去12个月自由现金流最近4个季度 | $41.7M | $87.1M |
8季度趋势，按日历期对齐
经营现金流PBYIPOWI
| Q4 25 | $14.4M | $26.2M | ||
| Q3 25 | $9.7M | $29.9M | ||
| Q2 25 | $14.1M | $29.1M | ||
| Q1 25 | $3.6M | $26.4M | ||
| Q4 24 | $15.6M | $14.7M | ||
| Q3 24 | $11.0M | $32.9M | ||
| Q2 24 | $1.0M | $17.6M | ||
| Q1 24 | $11.2M | $15.9M |
自由现金流PBYIPOWI
| Q4 25 | $14.4M | $19.2M | ||
| Q3 25 | $9.7M | $24.2M | ||
| Q2 25 | $14.1M | $23.1M | ||
| Q1 25 | $3.6M | $20.7M | ||
| Q4 24 | $15.6M | $11.7M | ||
| Q3 24 | $11.0M | $27.2M | ||
| Q2 24 | $1.0M | $13.5M | ||
| Q1 24 | — | $11.6M |
自由现金流率PBYIPOWI
| Q4 25 | 19.1% | 18.6% | ||
| Q3 25 | 17.7% | 20.3% | ||
| Q2 25 | 26.8% | 20.0% | ||
| Q1 25 | 7.7% | 19.6% | ||
| Q4 24 | 26.4% | 11.1% | ||
| Q3 24 | 13.7% | 23.5% | ||
| Q2 24 | 2.1% | 12.7% | ||
| Q1 24 | — | 12.6% |
资本支出强度PBYIPOWI
| Q4 25 | 0.0% | 6.8% | ||
| Q3 25 | 0.0% | 4.8% | ||
| Q2 25 | 0.0% | 5.1% | ||
| Q1 25 | 0.1% | 5.4% | ||
| Q4 24 | 0.0% | 2.9% | ||
| Q3 24 | 0.0% | 4.9% | ||
| Q2 24 | 0.0% | 3.9% | ||
| Q1 24 | 0.0% | 4.7% |
现金转化率PBYIPOWI
| Q4 25 | — | 1.97× | ||
| Q3 25 | 1.10× | — | ||
| Q2 25 | 2.41× | 21.24× | ||
| Q1 25 | 1.21× | 3.00× | ||
| Q4 24 | — | 1.61× | ||
| Q3 24 | 0.54× | 2.30× | ||
| Q2 24 | — | 3.64× | ||
| Q1 24 | — | 4.02× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PBYI
暂无分部数据
POWI
| Distributors | $65.8M | 64% |
| Other | $10.3M | 10% |
| KR | $9.3M | 9% |
| DE | $7.1M | 7% |
| TW | $5.5M | 5% |
| Emea Other Than Germany | $5.3M | 5% |
